Suppr超能文献

维拉帕米对儿童的电生理效应。

Electrophysiologic effects of verapamil in children.

作者信息

Shakibi J G, Kashani I A, Mehranpur M, Yazdanyar A

出版信息

Jpn Heart J. 1979 Nov;20(6):789-80. doi: 10.1536/ihj.20.789.

Abstract

The electrophysiologic effects of verapamil, a slow channel blocker, were investigated during diagnostic cardiac catheterization in 24 children premedicated with lytic cocktail. The ages ranged from 50 days to 12 years. Twenty had congenital and 4 had rheumatic heart disease. Surface EKG, high intra-atrial and His bundle electrograms were obtained in all before and 5 min after a single dose of verapamil (0.15 mg/Kg, max 5 mg iv). In 14 cases complete electropysiologic studies were performed using the atrial pacing and extrastimulus technique. Due to variability of the resting heart rates and the effect of cycle length on refractory periods each paced with identical S1-S1 interval before and after verapamil, thus allowing each case to serve as his own control. Verapamil prolonged the corrected AH interval in all (mean +/- SD; from 116 +/- 37 to 152 +/- 41 msec, p less than 0.01) and shortened the HV interval in 15/24 (mean +/- SD: from 55 +/- 13 to 47 +/- 9.9 msec, p less than 0.05). The effective and functional refractory periods of the total conduction system, the AV node (ERPAVN) and atrium (ERPA) increased significantly in 10/14. The most profound effect was on ERPAVN and ERPA (25.54 +/- 29 and 19.27 +/- 21.81 percent mean percent increase +/- SD respectively, p less than 0.01 and p less than 0.02). Our findings show that verapamil prolongs the effective and functional refractory periods of the cardiac conduction system with maximal effects on the AV node, thus suggesting the mechanism of its effectiveness in the treatment of reentrant supraventricular arrhythmias.

摘要

在对24例预先使用溶胞混合物进行预处理的儿童进行诊断性心导管插入术期间,研究了慢通道阻滞剂维拉帕米的电生理效应。年龄范围为50天至12岁。20例患有先天性心脏病,4例患有风湿性心脏病。在单剂量维拉帕米(0.15mg/Kg,最大5mg静脉注射)给药前和给药后5分钟,对所有患者均记录了体表心电图、高位心房电图和希氏束电图。14例患者采用心房起搏和额外刺激技术进行了完整的电生理研究。由于静息心率的变异性以及心动周期长度对不应期的影响,维拉帕米给药前后均以相同的S1-S1间期进行起搏,从而使每个病例都可作为自身对照。维拉帕米使所有患者的校正AH间期延长(平均值±标准差;从116±37毫秒延长至152±41毫秒,p<0.01),并使24例中的15例HV间期缩短(平均值±标准差:从55±13毫秒缩短至47±9.9毫秒,p<0.05)。14例中的10例,整个传导系统、房室结(ERPAVN)和心房(ERPA)的有效和功能不应期显著延长。最显著的影响是对ERPAVN和ERPA(平均增加百分比±标准差分别为25.54±29和19.27±21.81%,p<0.01和p<0.02)。我们的研究结果表明,维拉帕米可延长心脏传导系统的有效和功能不应期,对房室结的影响最大,从而提示其治疗折返性室上性心律失常有效性的机制。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验